ArticlePlastic and reconstructive surgery. Global open2025
Nationwide Medical Survey on Regional Disparities in Secondary Lymphedema Surgical Treatment Covered by Health Insurance.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lymphedema is a lifelong complication for cancer survivors, highlighting the need to address the regional disparities in its treatment. To assess the current regional disparities in surgical treatment for lymphedema, we conducted a comprehensive nationwide survey of medical institutions through questionnaires. Methods: Japanese surgical treatment facilities were categorized into 9 regions, distinguishing between designated cancer hospitals and other medical institutions, as well as high-volume and low-volume hospitals. We examined variations in the number of surgical procedures per capita across regions and analyzed differences in surgical indications between high-volume and low-volume hospitals based on the clinical classification of the International Society of Lymphology. Results: There was a 17.4-fold difference in the number of lymphedema surgical treatments per population between the region with the highest and lowest numbers. A strong correlation was found between the number of procedures in a region and the percentage of procedures performed at high-volume hospitals (ρ = 0.73, Conclusions: Significant regional variations exist in both the frequency of lymphedema surgery and surgical indication patterns across healthcare facilities, even in an environment where surgical treatment is covered by insurance. Standardized studies evaluating treatment outcomes are needed to assess the appropriateness of treatment indications.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.